Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 105-108

  Pikis, Andreas ^a   Donkersloot, Jacob A ^b   Akram, Shama ^a   Keith, Jerry M ^b   Campos, Joseph M ^c   Rodriguez, William J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CHLORAMPHENICOL; IMIPENEM; MEROPENEM; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEFOTAXIME; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; RIFAMPIN; STREPTOCOCCUS PNEUMONIAE; THIENAMYCINS; VANCOMYCIN;

EID: 0030809416     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.105     Document Type: Article

References (11)

1. Schreiber, J. R. & Jacobs, M. R. (1995). Antibiotic-resistant pneumococci. Pediatric Clinics of North America 42, 519-37.
2. Doit, C. P., Bonacorsi, S. P., Fremaux, A. J., Sissia, G., Cohen, R., Geslin, P. L. et al. (1994). In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Journal of Antimicrobial Chemotherapy 38, 2655-9.
3. Bradley, J. S. & Connor, J. D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatric Infectious Disease Journal 10, 871-3.
4. Catalán, M. J., Fernández, J. M., Vasquez, A., Varela de Seijas, E., Suárez, A. & Bernaldo de Quirós, J. C. (1994). Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clinical Infectious Diseases 18, 766-9.
5. Viladrich, P. F., Gudiol, F., Línares, J., Pallarés, R., Sabaté, I., Rufí, G. et al. (1991). Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 35, 2467-72.
6. Klugman, K. P., Friedland, I. R. & Bradley, J. S. (1995). Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrobial Agents and Chemotherapy 39, 1988-92.
7. Friedland, I. R. & Klugman, K. P. (1992). Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 339, 405-8.
8. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-5.
9. Asensi, F., Otero, M. C., Pérez-Tamarit, D., Rodríguez-Escribano, I., Cabedo, J. L., Gresa, S. et al. (1993). Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. Journal of Chemotherapy 5, 133-4.
10. Klugman, K. P., Dagan, R. & the Meropenem Meningitis Study Group. (1995). Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrobial Agents and Chemotherapy 39, 1140-6.
11. National Committee for Clinical Laboratory Standards. (1995). Performance Standards for Antimicrobial Susceptibility Testing: Sixth Informational Supplement. Document M100-S6. NCCLS, Villanova, PA.